IHS Chemical Week

People & Business :: Companies

Evonik: Ebitda falls 24% on organic sales growth of 1%; reiterates outlook for 2014

7:45 AM MDT | May 7, 2014 | Michael Ravenscroft

Evonik says it achieved sales of €320 billion ($4.45 billion) in first-quarter 2014, close to the prior-period level of €3.21 billion, a slight organic sales growth of 1% year-on- year. Higher volumes (5 percentage points) countered the drop in selling prices (4 percentage points), and adverse currency effects clipped sales by 1 percentage point, according to Evonik. Adjusted Ebitda slipped to €463 million, compared with €606 million in the year-ago quarter, or 24% YOY, falling short of the very good level in the prior-period, according to...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa